In contrast, we observed minimal differences in the levels of prostate and prostate cancer-associated proteins, including KLKB1, KLK2, KLK3, ACP3, and SLC45A3, which are markers of conventional adenocarcinoma of the prostate (Fig. 3g). This evidence concerns the gene KLK3 and prostate adenocarcinoma.